U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination
    • Showing Current items.

    GFAP glial fibrillary acidic protein [ Homo sapiens (human) ]

    Gene ID: 2670, updated on 4-Jan-2025

    GeneRIFs: Gene References Into Functions

    GeneRIFPubMed TitleDate
    Glial Fibrillary Acidic Protein Astrocytopathy: Review of Pathogenesis, Imaging Features, and Radiographic Mimics.

    Glial Fibrillary Acidic Protein Astrocytopathy: Review of Pathogenesis, Imaging Features, and Radiographic Mimics.
    Shetty D, Brahmbhatt S, Desai A, Bathla G, Mohan S, Gupta V, Soni N, Vibhute P, Agarwal A.,

    10/9/2024
    Amyloid-beta misfolding and GFAP predict risk of clinical Alzheimer's disease diagnosis within 17 years.

    Amyloid-beta misfolding and GFAP predict risk of clinical Alzheimer's disease diagnosis within 17 years.
    Beyer L, Stocker H, Rujescu D, Holleczek B, Stockmann J, Nabers A, Brenner H, Gerwert K.

    08/13/2024
    Glial fibrillary acidic protein is pathologically modified in Alexander disease.

    Glial fibrillary acidic protein is pathologically modified in Alexander disease.
    Lin NH, Jian WS, Snider N, Perng MD., Free PMC Article

    07/29/2024
    Relationship between increased serum neurofilament light chain and glial fibrillary acidic protein levels with non-motor symptoms in patients with Parkinson's disease.

    Relationship between increased serum neurofilament light chain and glial fibrillary acidic protein levels with non-motor symptoms in patients with Parkinson's disease.
    Yin P, Niu X, Guan C, Zhang Z, Liu Y, Li J, Cui G, Zan K, Xu C.

    03/6/2024
    Glial Fibrillary Acidic Protein: Diagnostic and Prognostic Role in Psychomotor Development Dynamics in Patients with Congenital Heart Defects after Cardiovascular Surgery.

    Glial Fibrillary Acidic Protein: Diagnostic and Prognostic Role in Psychomotor Development Dynamics in Patients with Congenital Heart Defects after Cardiovascular Surgery.
    Chiperi LE, Hutanu A., Free PMC Article

    03/4/2024
    Serum glial fibrillary acidic protein and disability progression in progressive multiple sclerosis.

    Serum glial fibrillary acidic protein and disability progression in progressive multiple sclerosis.
    Abdelhak A, Antweiler K, Kowarik MC, Senel M, Havla J, Zettl UK, Kleiter I, Skripuletz T, Haarmann A, Stahmann A, Huss A, Gingele S, Krumbholz M, Benkert P, Kuhle J, Friede T, Ludolph AC, Ziemann U, Kümpfel T, Tumani H., Free PMC Article

    02/20/2024
    The role of plasma neurofilament light chain and glial fibrillary acidic protein in subjective cognitive decline and mild cognitive impairment.

    The role of plasma neurofilament light chain and glial fibrillary acidic protein in subjective cognitive decline and mild cognitive impairment.
    Mazzeo S, Ingannato A, Giacomucci G, Bagnoli S, Cavaliere A, Moschini V, Balestrini J, Morinelli C, Galdo G, Emiliani F, Piazzesi D, Crucitti C, Frigerio D, Polito C, Berti V, Padiglioni S, Sorbi S, Nacmias B, Bessi V., Free PMC Article

    02/15/2024
    Plasma glial fibrillary acidic protein levels correlate with paramagnetic rim lesions in people with radiologically isolated syndrome.

    Plasma glial fibrillary acidic protein levels correlate with paramagnetic rim lesions in people with radiologically isolated syndrome.
    Schneider R, Brand-Arzamendi K, Reynold Lim T, Lee LE, Guenette M, Suthiphosuwan S, Bharatha A, Oh J.

    02/12/2024
    Associations of plasma NfL, GFAP, and t-tau with cerebral small vessel disease and incident dementia: longitudinal data of the AGES-Reykjavik Study.

    Associations of plasma NfL, GFAP, and t-tau with cerebral small vessel disease and incident dementia: longitudinal data of the AGES-Reykjavik Study.
    van Gennip ACE, Satizabal CL, Tracy RP, Sigurdsson S, Gudnason V, Launer LJ, van Sloten TT., Free PMC Article

    02/7/2024
    Astrocyte biomarkers GFAP and YKL-40 mediate early Alzheimer's disease progression.

    Astrocyte biomarkers GFAP and YKL-40 mediate early Alzheimer's disease progression.
    Pelkmans W, Shekari M, Brugulat-Serrat A, Sánchez-Benavides G, Minguillón C, Fauria K, Molinuevo JL, Grau-Rivera O, González Escalante A, Kollmorgen G, Carboni M, Ashton NJ, Zetterberg H, Blennow K, Suarez-Calvet M, Gispert JD, ALFA study., Free PMC Article

    01/26/2024
    Serum NfL and GFAP are associated with incident dementia and dementia mortality in older adults: The cardiovascular health study.

    Serum NfL and GFAP are associated with incident dementia and dementia mortality in older adults: The cardiovascular health study.
    Cronjé HT, Liu X, Odden MC, Moseholm KF, Seshadri S, Satizabal CL, Lopez OL, Bis JC, Djoussé L, Fohner AE, Psaty BM, Tracy RP, Longstreth WT Jr, Jensen MK, Mukamal KJ., Free PMC Article

    01/4/2024
    Alexander disease genetics: Beyond GFAP exon sequencing?

    Alexander disease genetics: Beyond GFAP exon sequencing?
    Cypers G.

    01/3/2024
    Neurofilament Light Chain and Glial Fibrillary Acidic Protein as early prognostic biomarkers after out-of-hospital cardiac arrest.

    Neurofilament Light Chain and Glial Fibrillary Acidic Protein as early prognostic biomarkers after out-of-hospital cardiac arrest.
    Klitholm M, Jeppesen AN, Christensen S, Parkner T, Tybirk L, Kirkegaard H, Sandfeld-Paulsen B, Grejs AM.

    12/21/2023
    Glial Fibrillary Acidic Protein (GFAP) Astrocytopathy: An Emerging Cause of Meningoencephalomyelitis in Children and Adolescents.

    Glial Fibrillary Acidic Protein (GFAP) Astrocytopathy: An Emerging Cause of Meningoencephalomyelitis in Children and Adolescents.
    Uppal P, Smith J, Castillo-Pinto C, Wells EM, Jayakar A, Harrar D.

    12/15/2023
    Serum beta-synuclein, neurofilament light chain and glial fibrillary acidic protein as prognostic biomarkers in moderate-to-severe acute ischemic stroke.

    Serum β-synuclein, neurofilament light chain and glial fibrillary acidic protein as prognostic biomarkers in moderate-to-severe acute ischemic stroke.
    Barba L, Vollmuth C, Abu-Rumeileh S, Halbgebauer S, Oeckl P, Steinacker P, Kollikowski AM, Schultz C, Wolf J, Pham M, Schuhmann MK, Heuschmann PU, Haeusler KG, Stoll G, Neugebauer H, Otto M., Free PMC Article

    12/1/2023
    Epstein-Barr virus: To be a trigger of autoimmune glial fibrillary acidic protein astrocytopathy?

    Epstein-Barr virus: To be a trigger of autoimmune glial fibrillary acidic protein astrocytopathy?
    Li XL, Wang JY, Li LK, Yang CL, Zhao XL, Yang B, Zhang P, Liu B, Li YB, Zhang ZX, Duan RS., Free PMC Article

    11/20/2023
    Plasma beta-synuclein, GFAP, and neurofilaments in patients with malignant gliomas undergoing surgical and adjuvant therapy.

    Plasma β-synuclein, GFAP, and neurofilaments in patients with malignant gliomas undergoing surgical and adjuvant therapy.
    Abu-Rumeileh S, Barba L, Bache M, Halbgebauer S, Oeckl P, Steinacker P, Güttler A, Keßler J, Illert J, Strauss C, Vordermark D, Otto M., Free PMC Article

    10/30/2023
    Overlapping Epstein-Barr virus encephalitis and autoimmune glial fibrillary acidic protein astrocytopathy.

    Overlapping Epstein-Barr virus encephalitis and autoimmune glial fibrillary acidic protein astrocytopathy.
    Zhang JR, Zhuang S, Xu XD, Song WL, Li KR, Jiang Y, Cheng XY, Shi JJ, Hu WD, Liu CF, Zhang YL.

    10/4/2023
    Clinical characteristics of autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy in children: A case series of 16 patients.

    Clinical characteristics of autoimmune glial fibrillary acidic protein (GFAP) astrocytopathy in children: A case series of 16 patients.
    Li T, Li X, Hong S, Jiang L, Ma J.

    10/4/2023
    Autoimmune glial fibrillary acidic protein astrocytosis mimicking tuberculous meningitis: a retrospective study.

    Autoimmune glial fibrillary acidic protein astrocytosis mimicking tuberculous meningitis: a retrospective study.
    Liang Y, Wang G, Li B, Li G, Zeng H., Free PMC Article

    09/23/2023
    Adult-onset Alexander disease with unusual inflammatory features and a novel GFAP mutation in two patients.

    Adult-onset Alexander disease with unusual inflammatory features and a novel GFAP mutation in two patients.
    Ziad F, Cypers G, Phillips M, Vanhoenacker P, Hostens A, Yadavraj S, Lamont D, Robertson T.

    09/1/2023
    Early neurofilament light and glial fibrillary acidic protein levels improve predictive models of multiple sclerosis outcomes.

    Early neurofilament light and glial fibrillary acidic protein levels improve predictive models of multiple sclerosis outcomes.
    Bose G, Healy BC, Saxena S, Saleh F, Paul A, Barro C, Lokhande HA, Polgar-Turcsanyi M, Anderson M, Glanz BI, Guttmann CRG, Bakshi R, Weiner HL, Chitnis T.

    06/23/2023
    The HOPX and BLBP landscape and gliogenic regions in developing human brain.

    The HOPX and BLBP landscape and gliogenic regions in developing human brain.
    Holst CB, Brøchner CB, Vitting-Seerup K, Møllgård K., Free PMC Article

    06/22/2023
    Glial fibrillary acidic protein is a robust biomarker in cerebrospinal fluid and peripheral blood after traumatic spinal cord injury: a prospective pilot study.

    Glial fibrillary acidic protein is a robust biomarker in cerebrospinal fluid and peripheral blood after traumatic spinal cord injury: a prospective pilot study.
    Wichmann TO, Kasch H, Dyrskog S, Høy K, Møller BK, Krog J, Hoffmann HJ, Hviid CVB, Rasmussen MM.

    06/2/2023
    GFAP as a Potential Biomarker for Alzheimer's Disease: A Systematic Review and Meta-Analysis.

    GFAP as a Potential Biomarker for Alzheimer's Disease: A Systematic Review and Meta-Analysis.
    Kim KY, Shin KY, Chang KA., Free PMC Article

    05/19/2023
    firstprevious page of 11 nextlast